NCT00453063View on ClinicalTrials.gov

Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

426

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

mometasone furoate

50 mcg/spray, two sprays in each nostril once daily (ie, 200 mcg QD) in the morning

DRUG

Placebo

Two sprays in each nostril once daily in the morning

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00453063 - Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED) | Biotech Hunter | Biotech Hunter